Literature DB >> 1940478

Intestinal secretory immune response to infection with Aeromonas species and Plesiomonas shigelloides among students from the United States in Mexico.

Z D Jiang1, A C Nelson, J J Mathewson, C D Ericsson, H L DuPont.   

Abstract

Intestinal secretory IgA (sIgA) response or lack of response among adults in Mexico with diarrhea was used as an indicator of enteropathogenicity of Aeromonas species and Plesiomonas shigelloides. sIgA was extracted from stool specimens obtained at day of presentation and 5 days later. Total sIgA was standardized, and specific sIgA titer against the organism being shed by each patient was determined. Western blotting was used to determine which microbial antigens elicited an intestinal sIgA response. Of 12 subjects shedding Aeromonas sobria or Aeromonas hydrophila, 11 had a fourfold or greater sIgA titer rise against the infecting strain. Western blotting showed that somatic lipopolysaccharides were the immunodominant antigens. No sIgA titer rises were detected among two patients shedding Aeromonas caviae or in 14 shedding P. shigelloides. This study provides further evidence of the significance of A. sobria and A. hydrophila as pathogens in acute diarrhea but raises additional questions about the role of P. shigelloides, at least in US adults with travelers' diarrhea.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1940478     DOI: 10.1093/infdis/164.5.979

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Intestinal secretory immunoglobulin A response to enteroaggregative Escherichia coli in travelers with diarrhea.

Authors:  M Sutjita; A R Bouckenooghe; J A Adachi; Z D Jiang; J J Mathewson; C D Ericsson; H L DuPont
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

2.  Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage.

Authors:  D Externest; B Meckelein; M A Schmidt; A Frey
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  Identification of Aeromonas strains to the genospecies level in the clinical laboratory.

Authors:  S L Abbott; W K Cheung; S Kroske-Bystrom; T Malekzadeh; J M Janda
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

4.  Inhibition of mammalian cathepsins by Plesiomonas shigelloides.

Authors:  A Pavlova; K Krovácek; I Ciznár; C Gonzalez-Rey
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

5.  Expression of hemolytic activity by Plesiomonas shigelloides.

Authors:  J M Janda; S L Abbott
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

6.  HEp-2 cell-adherent Escherichia coli and intestinal secretory immune response to human immunodeficiency virus (HIV) in outpatients with HIV-associated diarrhea.

Authors:  J J Mathewson; B M Salameh; H L DuPont; Z D Jiang; A C Nelson; R Arduino; M A Smith; N Masozera
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

7.  Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain.

Authors:  D Nardelli-Haefliger; J P Kraehenbuhl; R Curtiss; F Schodel; A Potts; S Kelly; P De Grandi
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

8.  Methods for detection of an intestinal secretory immunoglobulin A response to Candida spp. and their preliminary application in human immunodeficiency virus-infected patients with chronic diarrhea.

Authors:  E G Scerpella; S S Gould; J J Mathewson; H L DuPont
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

9.  Intestinal immune response of volunteers ingesting a strain of enteroadherent (HEp-2 cell-adherent) Escherichia coli.

Authors:  H F Gomez; J J Mathewson; P C Johnson; H L DuPont
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

10.  Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces.

Authors:  B Haneberg; D Kendall; H M Amerongen; F M Apter; J P Kraehenbuhl; M R Neutra
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.